Larvol Delta - GPNMBtargeting-Chimeric-Antigen-Receptor-TCell-Therapy-GCAR1-for-a-Patient-With-Alveolar-Soft-Part-Sarcoma-CLICYYCGPNMB02

GCAR1 - Alberta Health Services

http://clinicaltrials.gov/ct2/show/NCT06789081

Mar 24, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next